A Double-blind, Placebo-controlled, Single-dose Study to Evaluate the PK, IM, and Safety in Japanese Subjects

Inclusion Criteria: * Subject is of Japanese ethnicity * No evidence of clinically significant respiratory disease Exclusion Criteria: * Any condition that, would interfere with the evaluation of the study drug or safety of subjects. * Subject has a known hypersensitivity to any components of the investigational product. * History of infection requiring hospitalization or treatment with IV antibiotics within 12 weeks before screening, or evidence of clinically significant active infection. * Subject has a history or present condition of malignancy. * Subject has a history or presence of drug addiction (urine test) or has alcohol consumption (breath test) of more than 21 (males) or 14 (females) units of alcohol per week. * Any blood donation or significant loss of blood within 56 days of study initiation, * Receipt of live (attenuated) vaccine within the 4 weeks before screening or during the study.